In a filing, Arcutis Biotherapeutics Inc revealed its insider Matsuda Masaru unloaded Company’s shares for reported $76453.0 on May 02 ’25. In the deal valued at $15.20 per share,5,030 shares were sold. As a result of this transaction, Matsuda Masaru now holds 204,399 shares worth roughly $2.93 million.
Then, Watanabe Todd Franklin sold 11,448 shares, generating $173,917 in total proceeds. Upon selling the shares at $15.19, the insider now owns 913,795 shares.
Before that, Burnett Patrick sold 2,597 shares. Arcutis Biotherapeutics Inc shares valued at $39,442 were divested by the insider at a price of $15.19 per share. As a result of the transaction, Burnett Patrick now holds 119,339 shares, worth roughly $1.71 million.
H.C. Wainwright initiated its Arcutis Biotherapeutics Inc [ARQT] rating to a Buy in a research note published on December 30, 2024; the price target was $19. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. Mizuho also remained covering ARQT and has increased its forecast on January 03, 2024 with a “Buy” recommendation from previously “Neutral” rating. Mizuho revised its rating on October 26, 2023. It rated ARQT as “a Neutral” which previously was an “a Buy”.
Price Performance Review of ARQT
On Tuesday, Arcutis Biotherapeutics Inc [NASDAQ:ARQT] saw its stock fall -7.07% to $14.32. Over the last five days, the stock has lost -2.92%. Arcutis Biotherapeutics Inc shares have risen nearly 2.80% since the year began. Nevertheless, the stocks have risen 66.51% over the past one year. While a 52-week high of $17.75 was reached on 03/25/25, a 52-week low of $6.99 was recorded on 02/11/25. SMA at 50 days reached $14.71, while 200 days put it at $12.02.
Levels Of Support And Resistance For ARQT Stock
The 24-hour chart illustrates a support level at 13.91, which if violated will result in even more drops to 13.49. On the upside, there is a resistance level at 15.15. A further resistance level may holdings at 15.97. The Relative Strength Index (RSI) on the 14-day chart is 48.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.64, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 42.72%. Stochastics %K at 79.33% indicates the stock is a holding.
